Literature DB >> 16109445

Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.

Lorenzo Moretta1, Cristina Bottino, Daniela Pende, Massimo Vitale, Maria Cristina Mingari, Alessandro Moretta.   

Abstract

Natural killer cells represent a highly specialized lymphoid population with a potent cytolytic activity against virus-infected or tumor cells. Their function is regulated by a series of inhibiting or activating signals. The mechanisms by which NK cells kill susceptible target cells was thought to be elucidated after the discovery of inhibitory receptors specific for MHC-class I molecules: NK cells would kill those target cells that lack MHC-class I molecules. However, the actual scenario revealed more complex with the discovery of activating receptors and their ligands. Thus, in certain pathological conditions, corticosteroid treatment or exposure to TGFbeta, NK cells may under-express activating receptors. In addition, target cells may lack ligands for activating receptors and thus fail to activate NK cells upon cell-to-cell contact. This clearly implies that activation of NK cells and of their potent effector mechanism are under the control of different checkpoints.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109445     DOI: 10.1016/j.imlet.2005.07.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  38 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

3.  NKp30 is a functional activation receptor on a subset of rat natural killer cells.

Authors:  Christine L Hsieh; Kazuhito Nagasaki; Olivia M Martinez; Sheri M Krams
Journal:  Eur J Immunol       Date:  2006-08       Impact factor: 5.532

4.  Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.

Authors:  Mahyar Nouri-Shirazi; Saba Tamjidi; Erika Nourishirazi; Elisabeth Guinet
Journal:  Int Immunopharmacol       Date:  2018-05-24       Impact factor: 4.932

5.  Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells.

Authors:  Henry Ogbomo; Martin Michaelis; Janina Geiler; Marijke van Rikxoort; Thomas Muster; Andrej Egorov; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-12-15       Impact factor: 3.402

6.  The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells.

Authors:  Rivka Melamed; Ella Rosenne; Marganit Benish; Yael Goldfarb; Ben Levi; Shamgar Ben-Eliyahu
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

7.  Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.

Authors:  Henry Ogbomo; Martin Michaelis; Denise Klassert; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 8.  Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.

Authors:  M Campoli; S Ferrone
Journal:  Tissue Antigens       Date:  2008-08-12

9.  Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis.

Authors:  M Özgüler; H H Akbulut; A Akbulut
Journal:  West Indian Med J       Date:  2015-01-27       Impact factor: 0.171

10.  A novel system of polymorphic and diverse NK cell receptors in primates.

Authors:  Anne Averdam; Beatrix Petersen; Cornelia Rosner; Jennifer Neff; Christian Roos; Manfred Eberle; Fabienne Aujard; Claudia Münch; Werner Schempp; Mary Carrington; Takashi Shiina; Hidetoshi Inoko; Florian Knaust; Penny Coggill; Harminder Sehra; Stephan Beck; Laurent Abi-Rached; Richard Reinhardt; Lutz Walter
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.